Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cohn

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of the National Comprehensive Cancer Network : JNCCN|February 14, 2018
Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in OncologyWui-Jin Koh, Nadeem R Abu-Rustum, Sarah Bean, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in OncologyWui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 20, 2019
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in OncologyWui-Jin Koh, Nadeem R Abu-Rustum, Sarah Bean, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 20, 2021
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021Nadeem R Abu-Rustum, Catheryn M Yashar, Kristin Bradley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriersYuan C Ding, Lesley McGuffog, Sue Healey, et al.
Breast Cancer Research : BCR|February 22, 2012
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriersAntonis C Antoniou, Karoline B Kuchenbaecker, Penny Soucy, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of the National Comprehensive Cancer Network : JNCCN|February 14, 2018
Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in OncologyWui-Jin Koh, Nadeem R Abu-Rustum, Sarah Bean, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in OncologyWui-Jin Koh, Benjamin E Greer, Nadeem R Abu-Rustum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 20, 2019
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in OncologyWui-Jin Koh, Nadeem R Abu-Rustum, Sarah Bean, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 20, 2021
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021Nadeem R Abu-Rustum, Catheryn M Yashar, Kristin Bradley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriersYuan C Ding, Lesley McGuffog, Sue Healey, et al.
Breast Cancer Research : BCR|February 22, 2012
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriersAntonis C Antoniou, Karoline B Kuchenbaecker, Penny Soucy, et al.
Pageof 4